Core320: Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography

Sponsor
Johns Hopkins University (Other)
Overall Status
Completed
CT.gov ID
NCT00934037
Collaborator
Toshiba America Medical Systems, Inc. (Industry)
444
16
1
93
27.8
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the diagnostic accuracy of multi-detector computed tomography using 320 detectors for identifying the combination of coronary artery stenosis ≥ 50% and a corresponding myocardium perfusion defect in a patient with suspected coronary artery disease compared with conventional coronary angiography and single photon emission computed tomography myocardium perfusion imaging.

Condition or Disease Intervention/Treatment Phase
  • Procedure: 320 Volume Detector Computed Tomography
  • Other: Other: Multidetector Computed Tomography - 320 detectors
Phase 3

Detailed Description

The Combined Coronary angiography and myocardial perfusion imaging using 320 detectors computed tomography (CORE-320) was designed as a prospective, multi-center, international, blinded study designed to evaluate the diagnostic accuracy of multi-detector computed tomography using 320 detectors for identifying coronary artery luminal stenosis and corresponding myocardium perfusion defects in patients with suspected coronary artery disease. The primary analysis will be a comparison of the diagnostic capability of the combination of quantitative 320-MDCT angiography and quantitative perfusion imaging to the combination of conventional coronary angiography and SPECT myocardial perfusion imaging at the patient level. A positive patient will be defined as having at least one vessel with a ≥ 50% diameter stenosis defined by quantitative coronary angiography and a corresponding positive SPECT territorial myocardial perfusion defect.

Study Design

Study Type:
Interventional
Actual Enrollment :
444 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Multi Center Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320-Detector Computed Tomography
Actual Study Start Date :
Dec 1, 2009
Actual Primary Completion Date :
Sep 1, 2011
Actual Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Combined CT Angiography and Myocardial Perfusion

Single Arm study. All patients underwent combined CT Angiography and Myocardial Perfusion.

Procedure: 320 Volume Detector Computed Tomography
Single Arm Study. All patients undergo Volume (Multidetector) CT.

Other: Other: Multidetector Computed Tomography - 320 detectors
Multidetector computed tomography angiography
Other Names:
  • Aquilion ONE CT scanner
  • Outcome Measures

    Primary Outcome Measures

    1. Diagnostic accuracy of volume (multi-detector) computed tomography using 320 detectors in a patient with suspected coronary artery disease. [30-60 Days]

      Diagnostic accuracy of volume (multi-detector) computed tomography using 320 detectors for identifying coronary artery luminal stenosis and corresponding myocardium perfusion defects in a patient with suspected coronary artery disease.

    Secondary Outcome Measures

    1. Diagnostic accuracy of volume computed tomography using 320 detectors in a vessel of a patient with suspected coronary artery disease. [30-60 Days]

      Diagnostic accuracy of volume computed tomography using 320 detectors for identifying coronary artery luminal stenosis and corresponding territorial myocardium perfusion defects in a vessel of a patient with suspected coronary artery disease.

    2. Compare the relative diagnostic accuracy of 320 CT angiography vs SPECT in predicting at least one ≥ 50% coronary stenosis detected by QCA [30-60 Days]

      Compare the relative diagnostic accuracy of 320 CT angiography vs SPECT in predicting at least one ≥ 50% coronary stenosis detected by QCA

    3. Compare the relative diagnostic accuracy of 320 CT perfusion vs SPECT in predicting at least one ≥ 50% coronary stenosis detected by quantitative conventional angiography. [30-60 Days]

      Compare the relative diagnostic accuracy of 320 CT perfusion vs SPECT in predicting at least one ≥ 50% coronary stenosis detected by quantitative conventional angiography.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Male or female patients, age 45-85. Women of child bearing potential must demonstrate a negative pregnancy test within 24 hours of the study MDCT.

    • Suspected or diagnosed coronary artery disease with a clinical indication for coronary angiography; and planned coronary angiography within the next 60 days.

    • Able to understand and willing to sign the Informed Consent Form.

    Exclusion Criteria:
    • Known allergy to iodinated contrast media.

    • History of contrast-induced nephropathy.

    • History of multiple myeloma or previous organ transplantation.

    • Elevated serum creatinine (> 1.5 mg/dl) OR calculated creatinine clearance of < 60 ml/min (using the Cockcroft-Gault formula.

    • Atrial fibrillation or uncontrolled tachyarrhythmia, or advanced atrioventricular block (second or third degree heart block).

    • Evidence of severe symptomatic heart failure (NYHA Class III or IV); Known or suspected moderate or severe aortic stenosis.

    • Previous coronary artery bypass or other cardiac surgery.

    • Coronary artery intervention within the last 6 months.

    • Known or suspected intolerance or contraindication to beta-blockers including:

    • Known allergy to beta-blockers

    • History of moderate to severe bronchospastic lung disease (including moderate to severe asthma).

    • Severe pulmonary disease (chronic obstructive pulmonary disease).

    • Presence of any other history or condition that the investigator feels would be problematic.

    • SPECT preformed in non-validated center within 60 days prior to screening.

    • SPECT performed within the previous 6 months of screening but > 60 days.

    • SPECT studies performed within 60 days of screening that include rest and stress studies performed using 2 day protocols.

    • BMI greater than 40

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Johns Hopkins School of Medicine Baltimore Maryland United States 21205
    2 National Heart Lung and Blood Institute (NHLBI) Bethesda Maryland United States 20892
    3 Beth Israel Deaconess Medical Center Boston Massachusetts United States 02215
    4 Brigham and Women Hospital Boston Massachusetts United States 02215
    5 Albert Einstein Hospital Sao Paulo Brazil
    6 INCOR Heart Institute University-Sao Paulo Sao Paulo Brazil
    7 Toronto General Hospital Toronto Canada
    8 Rigshospitalet - University of Copenhagen Blegdamsvej Denmark 9, 2100
    9 Charite Humboldt University Berlin Germany
    10 Iwate Medical University Morioka Japan
    11 Keio University Tokyo Japan
    12 St. Luke's International Hospital Tokyo Japan
    13 Mie University TSU Japan
    14 Leiden University Leiden Netherlands
    15 Mount Elizabeth Hospital Singapore Singapore
    16 National Heart Center Singapore Singapore

    Sponsors and Collaborators

    • Johns Hopkins University
    • Toshiba America Medical Systems, Inc.

    Investigators

    • Study Chair: Joao AC Lima, MD MBA, Johns Hopkins School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Johns Hopkins University
    ClinicalTrials.gov Identifier:
    NCT00934037
    Other Study ID Numbers:
    • NA_00022661
    • Core320
    First Posted:
    Jul 8, 2009
    Last Update Posted:
    Sep 5, 2018
    Last Verified:
    Aug 1, 2018

    Study Results

    No Results Posted as of Sep 5, 2018